In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back. Pancreatic cancer is of particular concern. The five-year survival rate is about 13%, and up to 80% of pancreatic cancers may come back. “If you were to ask me what disease most needs something to prevent recurrences, I’d say this one,” said Dr. …
Read More »Pancreatic cancer vaccine prevents recurrence in Phase 1 clinical trial
